McGuireWoods advised underwriters in two recent public offerings that
showcased the firm’s deep securities and capital markets capabilities and
its industry-focused approach to client service.
The firm advised ThinkEquity, a division of Fordham Financial Management
Inc., as underwriter in a $28.75 million initial public offering of common
stock by TransCode Therapeutics Inc. The transaction closed on July 13,
ThinkEquity is a boutique investment bank created by experienced
professionals who have collectively financed over $50 billion of public and
private capital raises, restructurings, and mergers and acquisitions.
TransCode Therapeutics is an emerging RNA oncology company. Its lead
therapeutic candidate is focused on treating metastatic cancer, which
causes approximately 90 percent of all cancer deaths, representing over 9
million deaths per year worldwide.
The deal’s closing followed the firm’s representation of longtime client B.
Riley Securities Inc. (formerly National Securities Corp.) as underwriter
in a $13.5 million follow-on public offering of common shares by Manhattan
Bridge Capital Inc., a New York-based real estate finance company that
specializes in originating, servicing and managing a portfolio of first
McGuireWoods New York partner
Stephen Older and Charlotte partner
Rakesh Gopalan and counsel
David Wolpa led both deal teams, which included Richmond partner
Anitra Cassas and associate
Jessica Barrera and Charlotte associate Giles Beal. All are members of the firm’s Securities & Capital Markets
Department. Healthcare partner
Kate Hardey in Charlotte and associate
Royce DuBiner in Chicago assisted with regulatory analysis on the TransCode IPO.
“The TransCode IPO once again demonstrates our firm’s capabilities in
complex securities offerings, including initial public offerings and
underwriter-side work, as well as our depth of knowledge in the healthcare
and FDA regulatory space,” Older said. “The Manhattan Bridge Capital
transaction shows our ability to put together a team to tackle a
fast-moving transaction in a short time frame. We have a number of other
IPOs in the pipeline and see a strong pipeline on both the issuer and
McGuireWoods consistently ranks among the leading law firms for advising
corporate issuers and underwriters in U.S. capital markets transactions and
has earned global recognition for its work representing clients in
corporate and securities matters.